1684-4386

Clinical Microbiology and Antimicrobial Chemotherapy

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add license metadata to 391 records

License metadata tells indexers and readers how each article may be reused.

High impact391 DOIs
2

Attach ORCID iDs across 242 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact242 DOIs
3

Deposit reference lists for 86 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact86 DOIs

DOIs for this ISSN

Showing the top 5 of 354 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Antimicrobial resistance of nosocomial Enterobacterales isol… (10.36488/cmac.2019.2.147-159)
Abstract References License
132.26 57
2 Antimicrobial resistance of pathogens causing community-acqu… (10.36488/cmac.2019.2.134-146)
Abstract References License
120.96 40
3 AMRcloud: a new paradigm in monitoring of antibiotic resista… (10.36488/cmac.2019.2.119-124)
Abstract References License
108.54 27
4 Antimicrobial resistance, carbapenemase production, and geno… (10.36488/cmac.2019.2.160-170)
Abstract References License
102.13 22
5 Antimicrobial resistance, carbapenemase production, and geno… (10.36488/cmac.2019.2.171-180)
Abstract References License
99.17 20
6 Antimicrobial resistance of Gram-negative pathogens of nosoc… (10.36488/cmac.2019.1.62-68)
Abstract References ORCID License
95.42 8
7 Comparative review of the modern methods for carbapenemases… (10.36488/cmac.2019.2.125-133)
Abstract References License
94.15 17
8 Antimicrobal resistance of nosocomial carbapenemase-producin… (10.36488/cmac.2018.4.362-369)
Abstract References License
90.31 15
9 New probiotic strain Streptococcus salivarius K12 in clinica… (10.36488/cmac.2019.2.92-99)
Abstract References ORCID License
90.31 7
10 Application of AMRmap: «from the general to the specific» ap… (10.36488/cmac.2019.2.181-186)
Abstract References License
80.94 11
11 Antimicrobial resistance of clinical Streptococcus pneumonia… (10.36488/cmac.2019.3.230-237)
Abstract References License
80.94 11
12 Antibiotics and community-acquired lower respiratory tract i… (10.36488/cmac.2019.1.27-38)
Abstract References ORCID License
77.82 5
13 The evidence base and practical approaches to probiotic use… (10.36488/cmac.2019.2.100-118)
Abstract References ORCID License
77.82 5
14 Letter to editors (10.36488/cmac.2020.2.84-86)
References ORCID License
71.57 8
15 Acute liver failure in adults (10.36488/cmac.2019.1.46-55)
Abstract References ORCID License
69.90 4
16 The reasons why Klebsiella pneumoniae becomes a leading oppo… (10.36488/cmac.2020.1.4-19)
ORCID License
69.01 23
17 Characterization of genetic diversity of the Klebsiella pneu… (10.36488/cmac.2019.1.69-74)
Abstract References License
63.38 6
18 Burden of resistant infections caused by S. aureus, E. coli,… (10.36488/cmac.2018.4.310-318)
Abstract References ORCID License
60.21 3
19 Genotypes and metallo-beta-lactamases carriage in carbapenem… (10.36488/cmac.2018.4.370-374)
Abstract References ORCID License
60.21 3
20 Listeriosis: genotyping as a key for identification a possib… (10.36488/cmac.2019.4.261-273)
ORCID License
58.80 14
21 Gastrointestinal adverse drug reactions and antibiotic-assoc… (10.36488/cmac.2019.3.196-206)
Abstract References License
58.36 5
22 Determining knowledge of antimicrobial therapy in practition… (10.36488/cmac.2024.2.215-228)
References ORCID License
58.36 5
23 Biological characteristics and virulence of Helicobacter pyl… (10.36488/cmac.2018.1.14-23)
ORCID License
55.70 12
24 Vaccination against pneumococcal infections in adults (10.36488/cmac.2018.1.5-8)
References License
53.96 11
25 Antimicrobial resistance and antimicrobial therapy modificat… (10.36488/cmac.2021.3.293-303)
ORCID License
53.96 11
26 Detection of acquired carbapenemase genes among Acinetobacte… (10.36488/cmac.2019.1.56-60)
Abstract References License
52.42 4
27 New regimens and new medications in the treatment of tubercu… (10.36488/cmac.2021.1.27-42)
ORCID License
52.07 10
28 Antimicrobial resistance of nosocomial Enterococcus spp. iso… (10.36488/cmac.2018.2.142-149)
ORCID License
50.00 9
29 Susceptibility to antibiotic combinations among nosocomial c… (10.36488//cmac.2018.3.182-191)
ORCID License
47.71 8
30 Pharmacoepidemiology of peptic ulcer in Smolensk: 15 years l… (10.36488/cmac.2019.2.84-90)
Abstract References ORCID License
47.71 2
31 Species diversity and methicillin resistance in Staphylococc… (10.36488/cmac.2019.3.207-211)
Abstract References ORCID License
47.71 2
32 Management of antimicrobial resistance in a hospital: curren… (10.36488/cmac.2020.4.277-286)
ORCID License
47.71 8
33 Bacteriophage therapy: back to the future (10.36488/cmac.2021.1.55-64)
ORCID License
47.71 8
34 Comparison of the qSOFA and NEWS scores and the SIRS criteri… (10.36488/cmac.2019.1.18-25)
Abstract References License
45.15 3
35 Potential for the use of macrolides in the antimicrobial the… (10.36488/cmac.2019.3.217-223)
Abstract References License
45.15 3
36 Epidemiological significance of genome variations in Pseudom… (10.36488/cmac.2019.4.340-351)
ORCID License
45.15 7
37 Resistance of carbapenemase-producing Klebsiella pneumoniae… (10.36488/cmac.2020.1.47-52)
ORCID License
45.15 7
38 Mucormycosis: modern diagnostics and treatment, existing pro… (10.36488/cmac.2021.3.226-238)
ORCID License
45.15 7
39 AMRmap – antibiotic resistance surveillance system in Russia (10.36488/cmac.2021.2.198-204)
License
44.98 62
40 Epidemiology and impact of colonization by multidrug-resista… (10.36488/cmac.2022.4.375-382)
ORCID License
42.25 6
41 Mycoplasma pneumoniae – modern data on the structure, molecu… (10.36488/cmac.2023.4.332-349)
ORCID License
42.25 6
42 Etiological structure of infections in patients of the surgi… (10.36488/cmac.2024.2.124-140)
ORCID License
42.25 6
43 Susceptibility to antiseptic preparations in biofilm-forming… (10.36488/cmac.2018.3.249-256)
ORCID License
38.91 5
44 Mutations in the cytomegalovirus UL97 gene associated with g… (10.36488/cmac.2019.4.352-357)
ORCID License
38.91 5
45 Experience with the AMRcloud online platform for antimicrobi… (10.36488/cmac.2020.1.53-59)
ORCID License
38.91 5
46 Level of senior medical students’ knowledge on antimicrobial… (10.36488/cmac.2020.3.212-220)
ORCID License
38.91 5
47 Antibacterial agents reducing the risk of resistance develop… (10.36488/cmac.2021.2.184-194)
ORCID License
38.91 5
48 Prevalence of the A2058G mutation in 23S rRNA gene, which de… (10.36488/cmac.2022.4.369-374)
ORCID License
38.91 5
49 Antimicrobial therapy of sepsis caused by carbapenem-resista… (10.36488/cmac.2022.4.383-387)
ORCID License
38.91 5
50 Fusobacterium nucleatum: from a classic periodontal pathogen… (10.36488/cmac.2023.1.13-18)
ORCID License
38.91 5